Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Critical Reviews™ in Therapeutic Drug Carrier Systems

 

ISSN for PRINT: 0743-4863

Institutional price:

$1014.00

Issues per year:

6

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2004, Volume21

Issue 3

  132 pages  

DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i3   

click 'Save as...' here to save XML metadata

Issue price - $161.00  

Add to shopping cart

  • Mucosal Drug Delivery: Membranes, Methodologies, and Applications
  • Yifan Song
    Department of Pharmacology and Physiology, University of Medicine and Dentistry of New Jersey, Lab for Drug Delivery, Newark, New Jersey, USA

    Yiping Wang
    Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA

    Rashmi Thakur
    Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA

    Victor M. Meidan
    Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow, Scotland UK

    Bozena Michniak
    Department of Pharmacology and Physiology, University of Medicine and Dentistry of New Jersey, Lab for Drug Delivery, Newark, New Jersey; University of South Carolina, Basic Pharmaceutical Sciences, 700 Sumter St., Columbia, SC 29208, USA


    ABSTRACT

    In recent years, extensive research into novel forms of drug delivery has suggested that mucosal approaches offer a promising therapeutic alternative, especially for systemically acting drugs. Transmucosal drug delivery offers many benefits, including noninvasive administration, convenience, rapid onset, as well as elimination of hepatic first-pass metabolism. The investigated absorptive surfaces consist of the nasal, buccal, ocular, vaginal, and rectal mucosae. Among these, the nasal and buccal routes have proved the most promising to date. The bioavailability achieved mainly depends upon the pathophysiological state of the mucosa and the properties of both the drug and delivery systems. Various agents can increase the efficacy of transmucosal drug delivery. These include cyclodextrins, bile salts, surfactants, fusidic acid derivatives, microspheres, liposomes, and bioadhesive agents.The mechanisms of action, effectiveness, and toxicity profiles of these enhancers have been investigated extensively in both animal and human models.

    DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i3.20

    Download article, 62 pages

    Article price - $65.00  

    Add to shopping cart

    << Previous article  

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com